Ryan Leung is Vice President and Head of Life Science Product at Lila Sciences, where he leads product strategy and development for LILA's AI and autonomous laboratory platform across drug discovery, molecular design, and synthetic biology. He brings over a decade of experience across machine learning, biology, and medicine, with a career spanning discovery research, product management, and corporate strategy across therapeutic, diagnostic, and AI products.
Prior to LILA, Ryan held leadership roles at Genentech, Foundation Medicine, and PathAI, building and commercializing some of the earliest individualized cancer vaccines, comprehensive genomic profiling diagnostics, and computational pathology drug development tools. His work has consistently sat at the convergence of AI and life sciences, translating advances into products that impact patients and reshape how breakthroughs are built and brought to market.
Ryan holds a BS in Biomedical Engineering from Tufts University.
The latest from Lila Sciences
